Answers are grounded in this paper and cite their sources.
Background: Dry eye disease (DED) is a multifactorial ocular surface condition characterized by tear film instability, causing significant morbidity and reduced quality of life. We evaluated short-term clinical changes associated with use of a preservative-free ophthalmic spray based on the PER-LIP® complex (liposomes 4% + perilla seed extract 0.5%) combined with sodium hyaluronate 0.2%, delivered via an APTAR® multi-dose tip-seal system, in patients with mild-to-moderate DED. Methods: This prospective, single-arm, open-label interventional study enrolled patients with confirmed DED (OSDI > 13 and <50, plus at least one objective criterion). The spray was applied 3–4 times daily for 28 days. Outcomes assessed at baseline and Day 28 included OSDI, TBUT, Schirmer I, Oxford staining grade, central precorneal tear film thickness (CPTF), and BCVA. Phenotype analyses were performed by DED phenotype. Results: 36 patients (mean age 68.9 ± 12.2 years; 13 males, 23 females) participated in the study. Statistically significant improvements were observed in OSDI, TBUT, Oxford staining grade, CPTF, Schirmer I, and BCVA after 28 days. OSDI decreased from a median of 23 to 11 (p < 0.0001); TBUT increased from 6 s to 8 s (p < 0.0001); Oxford staining grade decreased from 1 to 0 (p < 0.0001); CPTF increased from 31 μm to 34 μm (p < 0.0001); Schirmer I changed from 9.5 mm to 10.5 mm (p = 0.0258); and BCVA changed from 0.9 to 1.0 (p = 0.0047). Phenotype analysis showed that TBUT improvement was significantly greater in the evaporative DED phenotype (p = 0.0018). Conclusions: A 28-day course of the PER-LIP® complex ophthalmic spray was associated with statistically significant short-term improvements across subjective and objective DED parameters. The differential TBUT response in the evaporative phenotype is hypothesis-generating and requires confirmation in controlled studies. The uncontrolled design, limited sample, exploratory subgroup analysis, and short observation period represent limitations of the outcomes.
No takes yet. Share an insight, caveat, or question.
Vicković et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: